Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinoma Of Esophagus”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT06030180
What this trial is testing

CLUE: CLinical Utility Study of EsoGuard

Who this might be right for
Barrett EsophagusBarretts Esophagus With DysplasiaEsophagus Adenocarcinoma
Lucid Diagnostics, Inc. 566
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07603375
What this trial is testing

Upfront Chemotherapy With Radiation Therapy (CRT) Followed by Chemotherapy in Localized Esophageal Adenocarcinoma

Who this might be right for
Esophageal Adenocarcinoma
Duke University 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT06680622
What this trial is testing

Bemarituzumab in FGFR2b+ Patients With Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction, Who Failed at Least One Prior Line of Palliative Chemotherapy

Who this might be right for
Metastatic Gastro-esophageal Adenocarcinoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest 126
Testing effectiveness (Phase 2)Looking for participantsNCT07222657
What this trial is testing

Liquid Nitrogen Spray Cryotherapy Prior to Neoadjuvant Systemic Therapy in Esophageal Adenocarcinoma

Who this might be right for
Esophageal AdenocarcinomaEsophageal Cancer
Case Comprehensive Cancer Center 40
Large-scale testing (Phase 3)Study completedNCT05568095
What this trial is testing

A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body

Who this might be right for
Advanced Upper Gastrointestinal Tract Adenocarcinoma
Arcus Biosciences, Inc. 1,040
Large-scale testing (Phase 3)Study completedNCT00020787
What this trial is testing

Vaccine Therapy Plus Chemotherapy in Treating Patients With Metastatic or Locally Recurrent Stomach Cancer or Esophageal Cancer

Who this might be right for
Esophageal CancerGastric Cancer
Jonsson Comprehensive Cancer Center 8
Not applicableNot Yet RecruitingNCT07439484
What this trial is testing

Individually Tailored, Supervised, Remote Exercise Intervention to Improve Physical Function for Stage I-III Gastroesophageal Cancer Survivors, PRECISE Trial

Who this might be right for
Clinical Stage I Esophageal Adenocarcinoma American Joint Committee on Cancer (AJCC) v8Clinical Stage I Esophageal Squamous Cell Carcinoma AJCC v8Clinical Stage I Gastric Cancer AJCC v8+9 more
Jonsson Comprehensive Cancer Center
Early research (Phase 1)Study completedNCT00002711
What this trial is testing

Combination Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus

Who this might be right for
Esophageal Cancer
Memorial Sloan Kettering Cancer Center 24
Early research (Phase 1)Study completedNCT03641547
What this trial is testing

M6620 Plus Standard Treatment in Oesophageal and Other Cancer

Who this might be right for
Oesophageal AdenocarcinomaSquamous Cell CarcinomaSolid Tumor
University of Oxford 36
Not applicableStudy completedNCT06381583
What this trial is testing

A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma

Who this might be right for
Esophagus CancerEsophageal Cancer StageEsophageal Cancer+18 more
City of Hope Medical Center 658
Testing effectiveness (Phase 2)Ended earlyNCT00848783
What this trial is testing

Irinotecan/Cisplatin, Potentially Curative Surgery With or Without Floxuridine, Followed by Capecitabine for Stomach and Gastro-esophageal Junction (GEJ) Cancers

Who this might be right for
Gastric CancerGastric AdenocarcinomaEsophageal Cancer
NYU Langone Health 8
Testing effectiveness (Phase 2)Study completedNCT00268346
What this trial is testing

Gefitinib in Treating Patients With Recurrent or Metastatic Esophageal or Gastroesophageal Junction Cancer

Who this might be right for
Esophageal Cancer
Case Comprehensive Cancer Center 58
Testing effectiveness (Phase 2)Looking for participantsNCT06005493
What this trial is testing

Study of AZD5863 in Adult Participants With Advanced or Metastatic Solid Tumors

Who this might be right for
Gastric CancerGastro-esophageal Junction CancerPancreatic Ductal Adenocarcinoma+1 more
AstraZeneca 392
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07059611
What this trial is testing

Neoadjuvant Intra-tumoral RP2 and FLOT in Gastroesophageal Adenocarcinoma

Who this might be right for
Gastric AdenocarcinomaEsophageal AdenocarcinomaGastroesophageal Junction Adenocarcinoma
Abramson Cancer Center at Penn Medicine 34
Testing effectiveness (Phase 2)Active Not RecruitingNCT04554771
What this trial is testing

Blood-borne Assessment of Stromal Activation in Esophageal Adenocarcinoma to Guide Tocilizumab Therapy

Who this might be right for
Esophageal AdenocarcinomaOesophageal AdenocarcinomaResectable Carcinoma
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 41
Testing effectiveness (Phase 2)UnknownNCT00005607
What this trial is testing

Combination Chemotherapy in Treating Patients With Metastatic or Recurrent Cancer of the Stomach or Esophagus

Who this might be right for
Esophageal CancerGastric Cancer
Robert H. Lurie Cancer Center
Early research (Phase 1)Looking for participantsNCT07090499
What this trial is testing

Learn About the Study Medicine Called PF-08046876 in People With Advanced Solid Tumors

Who this might be right for
Advanced/Metastatic Solid TumorsBladder CancerUrothelial Carcinoma+10 more
Pfizer 540
Early research (Phase 1)Ended earlyNCT05252416
What this trial is testing

(VELA) Study of BLU-222 in Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorsHR+ Breast CancerCCNE1 Amplification+6 more
Blueprint Medicines Corporation 50
Not applicableLooking for participantsNCT03452774
What this trial is testing

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Who this might be right for
Cancer, MetastaticCancerCancer of Pancreas+40 more
Massive Bio, Inc. 50,000
Not applicableLooking for participantsNCT05688176
What this trial is testing

Barrett's Esophagus and Esophageal Adenocarcinoma, Searching for Reliable Diagnostic RNA Plasma-based Biomarkers

Who this might be right for
Esophageal Neoplasms
University Hospital, Ghent 100
Next Page
20